Phil Ambery
Company: AstraZeneca
Job title: Global Clinical Head, CVRM
Seminars:
Patient Segmentation & Enhancing Understanding of Efficacy: Leveraging Machine Learning to Predict Fast Progressors & the Value of MRI 1:30 pm
Constructing a model to predict survival time of patients with NASH and/or portal hypertension, and identify fast progressors Evaluating current performance in treating patients with cirrhosis and features of portal hypertension, real-world evidence Non-invasive biomarkers for portal hypertension: HVPG vs integrating MRI into clinical trials to monitor therapeutic efficacyRead more
day: Day 2 Stream 2 PM